The FDA grants the company agreement under a Special Protocol Assessment to evaluate TRS01 ophthalmic solution for the treatment of non-infectious uveitis, including uveitic glaucoma.
Related Keywords
Colorado , United States , Daphne Haim Langford , University Of Colorado Department , Unsplash Perchek Industries , Drug Administration , Special Protocol Assessment ,
comparemela.com © 2020. All Rights Reserved.